Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Chapter
  • Print publication year: 2010
  • Online publication date: August 2010

Chapter 15 - Managing psychiatric aspects of seizure disorders

Export citation

Summary

Some familial preponderance with somatization disorder has been found in 10% to 20% of first-degree female relatives. An increased incidence of alcohol abuse, antisocial personality disorder, and depression has been reported in first-degree male relatives. The differential diagnosis includes anxiety disorders, factitious disorder, malingering, mood disorders, multi-system medical disorders, schizophrenia with somatic delusions, and other somatoform disorders. Cognitive-behavioral therapy (CBT) reduces disability, physical symptoms, and psychological distress for both somatoform disorders and medically unexplained physical symptoms. Caution is prudent in making this diagnosis as many organic disorders may present in a similar fashion to conversion disorders. Hypochondriasis (HC) is the misinterpretation of benign symptoms resulting in preoccupation with having a serious disease. Patients with body dysmorphic disorder (BDD) are thought to be fearful of negative appraisals from others, because of a bias for misinterpreting facial expressions as negative.

Keywords:

Related content

Powered by UNSILO

References

1. ElgerCE, SchmidtD. Modern management of epilepsy: a practical approach. Epilepsy Behav. 2008;12(4):501–39.
2. BrownTR, HolmesGL. Handbook of epilepsy. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
3. HauserWA, BeghiE. First seizure definitions and worldwide incidence and mortality. Epilepsia. 2008;49(Suppl 1):8–12.
4. HauserWA, RichSS, LeeJR, et al. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med. 1998;338(7):429–34.
5. HesdorfferDC, HauserWA. Epidemiological considerations. In: EttingerAB, KannerAM, editors. Psychiatric issues in epilepsy. 2nd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2007. p. 1–16.
6. de BoerHM, MulaM, SanderJW. The global burden and stigma of epilepsy. Epilepsy Behav. 2008;12(4):540–6.
7. Tellez-ZentenoJF, PattenSB, JetteN, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48(12):2336–44.
8. JonesJE, HermannBP, BarryJJ, et al. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci. 2005;17(2):172–9.
9. KannerAM. Peri-ictal psychiatric phenomena: clinical characteristics and implications of past and future psychiatric disorders. In: EttingerAB, KannerAM, editors. Psychiatric issues in epilepsy. 2nd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2007. p. 321–45.
10. SeptienL, GrasP, GiroudM, et al. Depression and temporal epilepsy: the possible role of laterality of the epileptic foci and of gender. Neurophysiol Clin. 1993;23(4):327–36.
11. LundJ. Epilepsy and psychiatric disorder in the mentally retarded adult. Acta Psychiatr Scand. 1985;72(6):557–62.
12. HermannBP, WhitmanS. Psychosocial predictors of interictal depression. J Epilepsy. 1989;2(4):231–7.
13. RothDL, GoodeKT, WilliamsVL, FaughtE. Physical exercise, stressful life experience, and depression in adults with epilepsy. Epilepsia. 1994;35(6):1248–55.
14. JacobyA, AustinJK. Social stigma for adults and children with epilepsy. Epilepsia. 2007;48(Suppl 9):6–9.
15. HermannBP, WhitmanS, WylerAR, et al. Psychosocial predictors of psychopathology in epilepsy. Br J Psychiatry. 1990;156:98–105.
16. AltshulerLL, DevinskyO, PostRM, TheodoreW. Depression, anxiety, and temporal lobe epilepsy: laterality of focus and symptoms. Arch Neurol. 1990;47(3):284–8.
17. TrostleJA, HauserWA, SharbroughFW. Psychologic and social adjustment to epilepsy in Rochester, Minnesota. Neurology. 1989;39(5):633–7.
18. KannerAM. Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 2009;15(1):83–7.
19. NadkarniS, ArnedoV, DevinskyO. Psychosis in epilepsy patients. Epilepsia. 2007;48(Suppl 9):17–9.
20. CarrenoM, DonaireA, Sanchez-CarpinteroR. Cognitive disorders associated with epilepsy: diagnosis and treatment. Neurologist. 2008;14(6 Suppl 1):S26–S34.
21. BearDM, FedioP. Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol. 1977;34(8):454–67.
22. BlumerD, MontourisG, DaviesK. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav. 2004;5(6):826–40.
23. MulaM, MonacoF. Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord. 2009;11(1):1–9.
24. BarryJJ, LembkeA, GisbertPA, GilliamF. Affective disorders in epilepsy. In: EttingerAB, KannerAM, editors. Psychiatric issues in epilepsy. 2nd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2007. p. 219.
25. MulaM, SanderJW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007;30(7):555–67.
26. SussmanN, EttingerAB. Psychotropic properties of antiepileptic drugs. In: EttingerAB, KannerAM, editors. Psychiatric issues in epilepsy. 2nd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2007. p. 67–82.
27. MulaM, TrimbleMR. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs. 2009;23(2):121–37.
28. U.S. Food and Drug Administration. Information for healthcare professionals: suicidality and antiepileptic drugs. January 1, 2008; cited 2009 May 1. Available from: http://www.fda.gov/Cder/Drug/InfoSheets/HCP/antiepilepticsHCP.htm.
29. BellGS, MulaM, SanderJW. Suicidality in people taking antiepileptic drugs: what is the evidence? CNS Drugs. 2009;23(4):281–92.
30. KarceskiS, MorrellMJ, CarpenterD. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav. 2005;7(Suppl 1):S1–S64.
31. HardenCL, MeadorKJ, PennellPB, et al. Practice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73(2):126–32.
32. ArifH, BuchsbaumR, WeintraubD, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology. 2007;68(20):1701–9.
33. MillerJW. Of race, ethnicity, and rash: the genetics of antiepileptic drug-induced skin reactions. Epilepsy Curr. 2008;8(5):120–1.
34. RamaratnamS, BakerGA, GoldsteinLH. Psychological treatments for epilepsy. Cochrane Database Syst Rev. 2008;(3):CD002029.
35. NakkenKO. Physical exercise in outpatients with epilepsy. Epilepsia. 1999;40(5):643–51.
36. FarooqS, SherinA. Interventions for psychotic symptoms concomitant with epilepsy. Cochrane Database Syst Rev. 2008;(4):CD006118.
37. KannerAM, GidalBE. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs. Int Rev Neurobiol. 2008;83:397–416.
38. KannerAM. The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin Neurol. 2008;28(3):379–88.